Literature DB >> 24035066

Incidence of acute myocardial infarction in first and second generation minority groups: does the second generation converge towards the majority population?

A A M van Oeffelen1, I Vaartjes, K Stronks, M L Bots, C Agyemang.   

Abstract

BACKGROUND: Differences in acute myocardial infarction (AMI) incidence between ethnic minority and migrant groups (henceforth, minority groups) and the majority population have been reported. Health differences may converge towards the majority population over generations. We assessed whether AMI incidence differences between minority groups living in the Netherlands and the Dutch majority population exist, and whether the incidence converges towards the majority population over generations.
METHODS: A nationwide register-based cohort study was conducted from 1997 to 2007. Using Cox Proportional Hazard Models AMI incidence differences between minorities and the majority population were estimated. When possible, analyses were stratified by generation.
RESULTS: AMI incidence differences between minorities and the majority population depended on the country of origin, and often varied between minorities originating from the same geographical region. For example, among North African and Mediterranean minorities, incidence was higher in Turkish (Hazard Ratio (HR): 1.34; 95% Confidence Interval (95% CI): 1.28-1.41), but lower in Moroccans (HR: 0.46; 95% CI: 0.40-0.52) compared with the majority population. Most minorities had a similar or lower incidence than the majority population, which remained similar or converged towards the incidence of the majority population over generations. In contrast, among minorities from the former Dutch colonies (Suriname, Indonesia, Netherlands Antilles) beneficial intergenerational changes were observed.
CONCLUSIONS: Health care professionals and policy makers should be aware of substantial AMI incidence differences between minority groups and the majority population, and the often unbeneficial change over generations. Future research should be cautious when clustering minority groups based on geographical region of the country of origin.
© 2013.

Entities:  

Keywords:  Cardiovascular disease; Ethnicity; Generation; Migrant; Minorities; Myocardial infarction

Mesh:

Year:  2013        PMID: 24035066     DOI: 10.1016/j.ijcard.2013.08.046

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Ethnic differences in coronary plaque and epicardial fat volume quantified using computed tomography.

Authors:  Daniel B Adams; Om Narayan; Ravi Kiran Munnur; James D Cameron; Dennis T L Wong; Andrew H Talman; Richard W Harper; Sujith K Seneviratne; Ian T Meredith; Brian S Ko
Journal:  Int J Cardiovasc Imaging       Date:  2016-09-26       Impact factor: 2.357

2.  2016 European Guidelines on cardiovascular disease prevention in clinical practice : The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts).

Authors:  Massimo F Piepoli
Journal:  Int J Behav Med       Date:  2017-06

3.  Ethnic inequalities in acute myocardial infarction hospitalization rates among young and middle-aged adults in Northern Italy: high risk for South Asians.

Authors:  Ugo Fedeli; Laura Cestari; Eliana Ferroni; Francesco Avossa; Mario Saugo; Pietro Amedeo Modesti
Journal:  Intern Emerg Med       Date:  2017-02-07       Impact factor: 3.397

4.  2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).

Authors:  Massimo F Piepoli; Arno W Hoes; Stefan Agewall; Christian Albus; Carlos Brotons; Alberico L Catapano; Marie-Therese Cooney; Ugo Corrà; Bernard Cosyns; Christi Deaton; Ian Graham; Michael Stephen Hall; F D Richard Hobbs; Maja-Lisa Løchen; Herbert Löllgen; Pedro Marques-Vidal; Joep Perk; Eva Prescott; Josep Redon; Dimitrios J Richter; Naveed Sattar; Yvo Smulders; Monica Tiberi; H Bart van der Worp; Ineke van Dis; W M Monique Verschuren; Simone Binno
Journal:  Eur Heart J       Date:  2016-05-23       Impact factor: 29.983

5.  Prevalence and management of cardiovascular risk factors in Portuguese living in Portugal and Portuguese who migrated to Switzerland.

Authors:  Luís Alves; Ana Azevedo; Henrique Barros; Peter Vollenweider; Gérard Waeber; Pedro Marques-Vidal
Journal:  BMC Public Health       Date:  2015-03-31       Impact factor: 3.295

6.  Higher self-reported prevalence of hypertension among Moluccan-Dutch than among the general population of The Netherlands: results from a cross-sectional survey.

Authors:  Junus M van der Wal; Adee J Bodewes; Charles O Agyemang; Anton E Kunst
Journal:  BMC Public Health       Date:  2014-12-15       Impact factor: 3.295

7.  Risk of disability pension in first and second generation immigrants: the role of age and region of birth in a prospective population-based study from Sweden.

Authors:  D Di Thiene; M Helgesson; K Alexanderson; G La Torre; J Tiihonen; E Mittendorfer-Rutz
Journal:  BMC Public Health       Date:  2017-12-04       Impact factor: 3.295

8.  Ethnic differences in cardiovascular morbidity and mortality among patients with breast cancer in the Netherlands: a register-based cohort study.

Authors:  Laura Deen; Josefien Buddeke; Ilonca Vaartjes; Michiel L Bots; Marie Norredam; Charles Agyemang
Journal:  BMJ Open       Date:  2018-08-17       Impact factor: 2.692

Review 9.  Cardiovascular health care and health literacy among immigrants in Europe: a review of challenges and opportunities during the COVID-19 pandemic.

Authors:  Bernhard Wernly; Sarah Wernly; Anthony Magnano; Elizabeth Paul
Journal:  Z Gesundh Wiss       Date:  2020-10-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.